Annotation Detail for CLTCL1

Basic Information
Top
Pathway ID | Pathway Name |
---|
| Membrane Trafficking |
Pathway ID | Pathway Name |
---|
P00026 | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway |
P00027 | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000638 |
Amiodarone |
Amiodarone results in increased expression of CLTCL1 mRNA | increases expression | 19774075
|
D002330 |
Carmustine |
Carmustine results in increased expression of CLTCL1 mRNA | increases expression | 15980968
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CLTCL1 mRNA | decreases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
4.25 | 18057881 20041841 18218290 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
4.23 | 19698954 18651412 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
4.38 | 19483382 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.83 | 16187019 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
3.01 | 19225199 15710769 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
5.83 | 18974383 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.82 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.24 | 19486331 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
2.48 | 15265979 18218290 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
9.49 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.49 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.79 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.96 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
4.19 | 16187019 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.16 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
4.40 | 15265979 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
4.36 | 9751232 8137927 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.23 | 10903974 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
5.17 | 18020914 17991464 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.56 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.12 | 12371664 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.82 | 15342952 17567588 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.92 | 15350150 17391786 11989578 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.65 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
5.34 | 18516814 |
MESH:D008545 |
Melanoma |
|
Carmustine |
2.91 | 12393984 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.65 | 16801185 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
5.77 | 17974566 12754197 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.70 | 18481113 19348381 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.64 | 12371664 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.34 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.98 | 11597910 12490602 12832656 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
5.83 | 18724381 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.79 | 18087811 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.87 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.77 | 19225199 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
5.62 | 19731979 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
5.51 | 18020914 19584973 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.93 | 17467628 11989578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.85 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.31 | 17120751 |